Quest Diagnostics Inc $63.45

up +1.03


16/9/2014 01:31 PM  |  NYSE : DGX  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get DGX Trend Analysis - it has underperformed the S&P 500 by 16%

Partner Headlines

  1. Quest Diagnostics Added To Goldman Sachs Conviction Buy List

    Benzinga
  2. Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With ...

    Benzinga
  3. LabCorp: A Leading Independent Diagnostic Laboratory

    GuruFocus
  4. Air Methods Navigates To Grow Medical Flight Business

    IBD
  5. Myriad Genetics Guidance Disappoints, Q4 Edges Views

    IBD
  6. Myriad Genetics' Earnings Face 'Angelina Jolie' Comps

    IBD
  7. Bernard Horn Comments on Quest Diagnostics

    GuruFocus
  8. Earnings Scheduled For July 24, 2014

    Benzinga
  9. Analyzing Stock Buybacks For Value Creation

    YCharts
  10. Top Five Guru-Owned Mid Cap Stocks

    GuruFocus
  11. Bloody Disruption: New Threat to Quest, LabCorp

    YCharts
  12. Mid-Day Market Movers For Monday, June 16, 2014

    Benzinga
  13. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  14. Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S

    GuruFocus
  15. UPDATE: Bank Of America Upgrades Quest Diagnostics On Near-Term Outlook

    Benzinga
  16. Benzinga's Top Upgrades

    Benzinga
  17. Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B

    GuruFocus
  18. Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S

    GuruFocus
  19. Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B

    GuruFocus
  20. Tool: Find Stocks Benefitting From Smart Buybacks

    YCharts
  21. Earnings Scheduled For April 24, 2014

    Benzinga
  22. Quest Diagnostics Extends Partnership with Steward Health Care System

    Benzinga
  23. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  24. Morning Coffee: Stocks at Historical Low P/B and P/S

    GuruFocus
  25. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  26. US Stock Futures Edge Lower Ahead Of Wholesale Trade Data

    Benzinga
  27. Diamond Hill Capital Comments on Quest Diagnostics

    GuruFocus
  28. Stocks Hitting 52-Week Lows

    Benzinga
  29. UPDATE: Quest Diagnostics Posts Higher Q4 Profit, Issues Downbeat 2014 ...

    Benzinga
  30. Earnings Scheduled For January 30, 2014

    Benzinga
  31. Quest Buys Solstas Lab for $570M

    FoxBusiness
  32. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  33. Quest Diagnostics Adds Timothy L. Main to Board of Directors

    Benzinga
  34. UC San Francisco, Quest Diagnostics Form Collaboration

    Benzinga
  35. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  36. 5 Leadership Traits That Stock Investors Should Look For

    GuruFocus
  37. Numerous Gurus Hold IDCC, DGX, PTR at 10-Year Low P/B

    GuruFocus
  38. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  39. UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple ...

    Benzinga
  40. Hologic's Opportunity (Icahn Sees It. Do You?)

    GuruFocus
  41. DGX, STO, LSE:DOM - Gurus Hold Stocks Traded at 10-Year Low P/B

    GuruFocus
  42. Quest, LabCorp Plunge: Buying Opportunity?

    YCharts
  43. UPDATE: Morgan Stanley Removes PT on Quest Diagnostics on Model Update ...

    Benzinga
  44. UPDATE: Bank of America Downgrades Quest Diagnostics on Reduced 2014 EPS ...

    Benzinga
  45. Benzinga's Top Downgrades

    Benzinga
  46. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  47. Dividends Are Still The Yield That Matters

    YCharts
  48. Benzinga's Top Initiations

    Benzinga
  49. Danaher Hits New High After Q3 Earnings Beat

    IBD
  50. Earnings Scheduled For October 17, 2013

    Benzinga
Trading Center